We could not find any results for:
Make sure your spelling is correct or try broadening your search.
European equities dropped in early trade Wednesday, with persistent geopolitical tensions in the Middle East offsetting the impact of upbeat U.S. consumer confidence data. At least 50 people were...
By Josie Cox European equities dropped in early trade Wednesday, with persistent geopolitical tensions in the Middle East offsetting the impact of upbeat U.S. consumer confidence data. At least 50...
ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended Marchย 31, 2014...
The medical devices industry, which was once acclaimed for its high-paying jobs and research and development opportunities, has been subject to the much controversial 2.3% medical device excise...
Health Care Stocks on our Radar -- Research on Abbott Laboratories, Medtronic, Hologic, and ArthroCare Editor Note: For more information about this release, please scroll to bottom PR...
Appointments, Stock Price Updates, Acquisitions, Financial Results and Technology Deployments - Analyst Notes on Stryker, ArthroCare, Novavax, Cooper, and Varian Editor Note: For more information...
Pre-Market Health Care Stocks Analysis: Medtronic, Abbott Laboratories, Hologic, and ArthroCare Editor Note: For more information about this release, please scroll to bottom. PR Newswire LONDON...
Stock Price Updates, Appointment, and Financial Results - Analyst Notes on Regeneron, DENTSPLY, AMAG, Cadence, and ArthroCare Editor Note: For more information about this release, please scroll...
ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended and year ended...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions